Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR

Go back to Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
(NASDAQ: ENSC) Delayed: 0.44 --0 (-0%)
Previous Close $0.44    52 Week High
Open $0.44    52 Week Low
Day High $0.44    P/E N/A 
Day Low $0.44    EPS
Volume 41,436